COMMUNIQUÉS West-GlobeNewswire
-
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026 -
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
02/06/2026 -
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
02/06/2026 -
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026 -
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026 -
OncoBag launches innovative handbag for post-mastectomy women
02/06/2026 -
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
02/06/2026 -
Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout
02/06/2026 -
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
02/06/2026 -
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
02/06/2026 -
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026 -
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
02/06/2026 -
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
02/06/2026 -
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026 -
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026 -
Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
02/06/2026 -
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
02/06/2026 -
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
02/06/2026 -
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
02/06/2026
Pages